Australia markets closed

Rhythm Pharmaceuticals, Inc. (RYTM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
37.96-1.21 (-3.09%)
At close: 04:00PM EDT
38.93 +0.97 (+2.56%)
After hours: 04:25PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-273,871
-184,678
-181,119
-69,612
-133,996
Depreciation & amortisation
1,706
1,758
1,672
1,158
690
Stock-based compensation
33,944
32,553
19,831
20,804
17,455
Change in working capital
-135
4,807
-17,410
1,897
-5,895
Accounts receivable
-6,578
-8,643
-5,199
-1,250
-
Inventory
-3,020
-5,707
-2,806
-11
-
Accounts payable
8,355
14,773
1,543
18,312
-6,446
Other working capital
-140,467
-136,204
-177,709
-151,437
-122,194
Other non-cash items
108,312
19,428
5,122
-250
-234
Net cash provided by operating activities
-140,467
-136,157
-173,428
-146,003
-121,980
Cash flows from investing activities
Investments in property, plant and equipment
-
-47
-4,281
-5,434
-214
Purchases of investments
-285,274
-354,918
-251,937
-524,972
-86,869
Sales/maturities of investments
332,342
354,967
284,247
361,247
245,614
Other investing activities
-41,147
-5,667
-
-
-
Net cash used for investing activities
5,921
-5,665
28,029
-62,159
158,531
Cash flows from financing activities
Common stock issued
-
48,875
131,112
161,726
0
Other financing activities
15,540
16,972
72,338
-
-
Net cash used provided by (used for) financing activities
78,744
74,368
213,828
166,481
2,009
Net change in cash
-56,101
-67,596
68,429
-41,681
38,560
Cash at beginning of period
109,989
128,005
59,576
101,257
62,697
Cash at end of period
54,187
60,409
128,005
59,576
101,257
Free cash flow
Operating cash flow
-140,467
-136,157
-173,428
-146,003
-121,980
Capital expenditure
-
-47
-4,281
-5,434
-214
Free cash flow
-140,467
-136,204
-177,709
-151,437
-122,194